1-20 of 22
Tsai-Yun Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 1/2a trial of amsulostat, a novel pan-lysyl oxidase inhibitor, in patients with advanced myelofibrosis as an add-on to ruxolitinib treatment for up to 52 weeks

Free
Ross Baker, Chih-Cheng Chen, Tsai-Yun Chen, Stanley Cheung, Hui-Hua Hsiao, Jae Hoon Lee, Ji Yun Lee, Sung-Eun Lee, Won Sik Lee, Lucia Masarova, Peter Tan, Shuhying Tan, Pankit Vachhani, Anne Marie Watson, Shang-Ju Wu, Jana Baskar, Joanna Leadbetter, Wolfgang Jarolimek
Journal: Blood
Blood (2025) 146 (Supplement 1): 2027.
https://doi.org/10.1182/blood-2025-2027
Published: 2025
Journal Articles

Genetic evolution in CML patients from diagnosis to TKI failure: An analysis of 121 paired diagnosis and treatment failure samples

Free
Ying-Jung Huang, Ming-Chung Kuo, Tung-Liang Lin, Ming-Chun Ma, Chieh-Lin Jerry Teng, Young-Sen Yang, Tsai-Yun Chen, Chiu-Chen Chen, Cheng-Shyong Chang, Hung Chang, Ting-Yu Huang, Tung-Huei Lin, Yen-Min Huang, Su-Peng Yeh, Ming-Chung Wang, Lee-Yung Shih
Journal: Blood
Blood (2025) 146 (Supplement 1): 5555.
https://doi.org/10.1182/blood-2025-5555
Published: 2025
Journal Articles

Immunophenotypic and cytokine profiling reveal robust immunomodulation after dasatinib treatment and identify a subgroup with rapid and deep molecular response in CML patients: A multi-center prospective study

Free
Shih-Feng Cho, Tsai-Yun Chen, Ying-Chung Hong, Ming-Chung Wang, Yu-Fen Tsai, Tsung-Jang Yeh, Hung-Pin Tu, Sin-Hua Moi, Hui-Ching Wang, Jeng-Shiun Du, Yuh-Ching Gau, Ching-I Yang, Ching-Ping Lee, Wen-Hsin Chang, Chin-Mu Hsu, Hui-Hua Hsiao, YI-Chang Liu
Journal: Blood
Blood (2025) 146 (Supplement 1): 1975.
https://doi.org/10.1182/blood-2025-1975
Published: 2025
Journal Articles

Identification of factors associated with a high success rate of treatment-free remission in chronic myeloid leukemia: A multicenter study in Taiwan

Free
Ning-Chun Chen, Ming-Chung Kuo, Tung-Huei Lin, Ming-Chun Ma, Ching-Yuan Kuo, Hung Chang, Hsuan-Jen Shih, Tung-Liang Lin, Hsiao-Wen Kao, Chang-Liang Lai, Tsai-Yun Chen, Chih-Cheng Chen, Ming-Chung Wang, Lee-Yung Shih
Journal: Blood
Blood (2025) 146 (Supplement 1): 3781.
https://doi.org/10.1182/blood-2025-3781
Published: 2025
Journal Articles

Multicenter, Open-Label Phase 1/2a Study of Pxs-5505 and Ruxolitinib in Patients with Primary, Post-Polycythemia Vera (PV) or Post-Essential Thrombocythemia (ET) Myelofibrosis

Free
Peter Tan, Ross Baker, Sung-Eun Lee, Anne Marie Watson, Stanley Cheung, Shang-Ju Wu, Chih-Cheng Chen, Shuhying Tan, Pankit Vachhani, Tsai-Yun Chen, Jae Hoon Lee, Hui-Hua Hsiao, Ji Yun Lee, Won Sik Lee, Lucia Masarova, Jana Baskar, Wolfgang Jarolimek, Joanna Leadbetter
Journal: Blood
Blood (2024) 144 (Supplement 1): 1001.
https://doi.org/10.1182/blood-2024-204290
Published: 2024
Journal Articles

Trial in Progress: Odronextamab for the Treatment of Patients with Relapsed/Refractory Mantle Cell Lymphoma Following Prior BTK Inhibitor Therapy - a Cohort of the ELM-2 Study

Free
Seok-Goo Cho, Tae Min Kim, Michal Taszner, Tsai-Yun Chen, Aafia Choudhry, Melanie Ufkin, Amulya Uppala, Ayesha Sabir, Hesham Mohamed, Srikanth Ambati, Emmanuel Bachy
Journal: Blood
Blood (2024) 144 (Supplement 1): 6302.
https://doi.org/10.1182/blood-2024-200770
Published: 2024
Journal Articles

A Phase 3, Randomized, Double-Blind, Active-Comparator-Controlled Study of Bomedemstat Versus Hydroxyurea in Patients with Essential Thrombocythemia Naïve to Cytoreductive Therapy

Free
Yuka Sugimoto, Eran Zimran, Yoshimitsu Shimomura, Hiroki Yamaguchi, Hans Carl Hasselbach, Jean-Jacques Kiladjian, Steffen Koschmeider, Harinder Gill, Kristen Pettit, David M Ross, Claire Harrison, Alejandro Berkovits, Ahmet Muzaffer Demir, Tsai-Yun Chen, Stefan Scheding, Claudia Barrera Carmona, Alessandro Vannuchi, Shiyu Zhang, Uzor C. Ogbu, Keita Kirito
Journal: Blood
Blood (2024) 144 (Supplement 1): 4569.3.
https://doi.org/10.1182/blood-2024-200881
Published: 2024
Journal Articles

Outcomes By Refractory Status and Prior Therapies Received in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) from the ECHELON-3 Study

Free
Uwe Hahn, Nancy L. Bartlett, Jeong-A Kim, Krimo Bouabdallah, Nicholas Forward, Tsai-Yun Chen, Vincent Camus, Ming-Chung Wang, Philippe Carassou, Enrico Derenzini, Hung Chang, Fritz Offner, Herve Ghesquieres, Grzegorz S. Nowakowski, Christopher Yasenchak, Monica Patterson, Linda Ho, Evelyn Rustia, Michelle Fanale, Keenan Fenton, Craig A. Portell
Journal: Blood
Blood (2024) 144 (Supplement 1): 4489.
https://doi.org/10.1182/blood-2024-200914
Published: 2024
Journal Articles

Sequential Bruton Tyrosine Kinase Inhibitor Therapy in Relapsed or Refractory Mantle Cell Lymphoma Following Chemotherapy: Real-World Outcomes and Attrition Rates - an Updated Report from the Asia-Pacific Multinational Retrospective Registry

Free
Hyungwoo Cho, Dok Hyun Yoon, Jason Yongsheng Chan, Dajung Kim, Haiwen Huang, Qingqing Cai, Tongyu Lin, Koji Kato, Udomsak Bunworasate, Sen Mui Tan, Ka-Won Kang, Jae-Yong Kwak, Tsai-Yun Chen, Jeong-Ok Lee, Seong Hyun Jeong, Young Rok Do, Esther Chan, Hye Jin Kang, Hyun-Seok Uhm, Sung Yong Oh, Youngil Koh, Hyo Jung Kim, Se Hyung Kim, Jong Ho Won, Young Hoon Park, Deok-Hwan Yang, Soo Chin Ng, Jae-Cheol Jo, Won Seog Kim
Journal: Blood
Blood (2024) 144 (Supplement 1): 1636.
https://doi.org/10.1182/blood-2024-202823
Published: 2024
Journal Articles

Dose Escalation of HLA-A2-WT1 CD3 T-Cell Bispecific Antibody in a Phase I Study in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)

Free
Martin Hutchings, Pau Montesinos, Armando Santoro, Hsin-An Hou, Maria Pilar Martinez-Sanchez, Susana Vives, Sara Galimberti, Tsai-Yun Chen, Marco Frigeni, Sylvain Garciaz, Olga Salamero, Su-Peng Yeh, Karen Yee, Gabriel Schnetzler, Teresa Barata, Silke Simon, Heather Hinton, Koorosh Korfi, Muriel Richard, Nino Keshelava, Marion Subklewe
Journal: Blood
Blood (2023) 142 (Supplement 1): 1537.
https://doi.org/10.1182/blood-2023-173302
Published: 2023
Journal Articles

Treatment Patterns in Patients with Mantle Cell Lymphoma: Updated Report of the Asia-Pacific Multinational Retrospective Registry Study

Free
Hyungwoo Cho, Dok Hyun Yoon, Jason Yongsheng Chan, Dajung Kim, Haiwen Huang, Qingqing Cai, Yu Fang, Tongyu Lin, Koji Kato, Udomsak Bunworasate, Sen Mui Tan, Ka-Won Kang, Jae-Yong Kwak, Tsai-Yun Chen, Jeong-Ok Lee, Seong Hyun Jeong, Young Rok Do, Esther Hian Li Chan, Hye Jin Kang, Hyeon-Seok Eom, Sung Yong Oh, Youngil Koh, Hyo Jung Kim, Se Hyung Kim, Jong-Ho Won, Young Hoon Park, Deok-Hwan Yang, Soo Chin Ng, Jae-Cheol Jo, Won Seog Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 6638.
https://doi.org/10.1182/blood-2023-183100
Published: 2023
Journal Articles

Results of Intercontinental Cooperative Non-Hodgkin T-Cell Lymphoma Prospective Registry Study

Free
Sang Eun Yoon, Seok Jin Kim, MD PhD, Tsai-Yun Chen, MD, Yong Park, Li Mei Poon, MBBS, MRCP, FRCPath, Young Rok Do, PhDMD, Ho Sup Lee, MD PhD, Won Sik Lee, MD PhD, Hong-ghi Lee, MD PhD, Soon Thye Lim, MBBS, MRCP, Hye Jin Kang, MD PhD, Cosphiadi Irawan, Jae Joon Han, MD PhD, Hyo Jung Kim, MD PhD, Cheolwon Suh, Hwan Jung Yun, MD, Soo Chin Ng, FRCP, Jae-Cheol Jo, MD PhD, Byeong Seok Sohn, MD PhD, Sung Yong Oh, Yeung-Chul Mun, MD, Daryl Tan, MBBS, MRCP, Seong Kyu Park, MD, Jae-Yong Kwak, MD PhD, Ye Guo, MD PhD, Huilai Zhang, MD, Jun Zhu, MD PhD, Weili Zhao, MD PhD, Won Seog Kim, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4035.
https://doi.org/10.1182/blood-2019-126637
Published: 2019
Journal Articles

Idiopathic plasmacytic lymphadenopathy with polyclonal hypergammaglobinemia mimicking plasma cell myeloma

Free
Chih-Chieh Yen, Tsai-Yun Chen
Journal: Blood
Blood (2018) 132 (25): 2700.
https://doi.org/10.1182/blood-2018-07-863290
Published: 2018
Journal Articles

Differential Impact of Conditioning Intensity on Post-Transplant Outcome of FLT3 -Mutated and FLT3 Wild Type AML in First Remission, a Report from Taiwan Bone Marrow Transplant Registry (TBMTR)

Free
Su-Peng Yeh, MD, Ming Yao, MD, Jih-Luh Tang, MD,PhD, Jin-Hwang Liu, MD PhD, Tzeon-Jye Chiou, MD, Tran-Der Tan, Po-Nan Wang, MD, Yeu-Chin Chen, MD, Wen-Li Hwang, MD, Ciyuan-jheng Wang, MD, Tsai-Yun Chen, MD, TA-Chih LIU, MD PhD, Ming-Sun Yu, MD, Tso-Fu Wang
Journal: Blood
Blood (2017) 130 (Supplement 1): 3229.
https://doi.org/10.1182/blood.V130.Suppl_1.3229.3229
Published: 2017
Journal Articles

Comparison of Molecular Responses between e14a2 and e13a2 BCR-ABL1 Transcripts in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Front-Line Second Generation Tyrosine Kinase Inhibitors: Taiwan CML Study

Free
Yi-Jiun Su, MD, Ming-Chung Kuo, MD, Chieh-Lin Teng, MD, Tsai-Yun Chen, MD, Ming-Chun Ma, MD, Pei-Ching Hsiao, MD, Ming-Chung Wang, MD, Tung-Huei Lin, MS, Wen-Li Hwang, MD, Chih-Cheng Chen, MD, Youngsen Yang, MD, Sung-Nan Pei, MD, Yen-Min Huang, MD, Sin-Syue Li, MD, Ming-Yang Lee, MD, Hung-I Cheng, MD, Lee-Yung Shih, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1603.
https://doi.org/10.1182/blood.V130.Suppl_1.1603.1603
Published: 2017
Journal Articles

Safety and Efficacy of Nilotinib (NIL) in Patients (Pts) with Chronic Phase (CP) or Accelerated Phase (AP) Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML) with Resistance or Intolerance to Imatinib Mesylate (IM): Results from the Multicenter, Observational NOVEL Study in Taiwan

Free
Ching-Yuan Kuo, MD, Po-Nan Wang, MD, Wen Li Hwang, MD, Cheng-Hwai Tzeng, MD, Li-Yuan Bai, MD, Jih-Luh Tang, MD PhD, Ming-Chih Chang, MD, Sheng-Fung Lin, MD, Tsai-Yun Chen, MD, Yeu-Chin Chen, MD, Tran-Der Tan, MD, Chih-Yi Hseih, MD, Chinjune Lin, MD, Miljkovic Darko, MD, Chang Cheng-Shyong, MD
Journal: Blood
Blood (2015) 126 (23): 1593.
https://doi.org/10.1182/blood.V126.23.1593.1593
Published: 2015
Journal Articles

A Retrospective Multicenter Study to Evaluate the Efficacy of Rabbit Antithymocyte Globulin (rATG) Immunosuppressive Therapy As First-Line Treatment of Aplastic Anemia

Free
Suporn Chuncharunee, MD, Raymond SM Wong, MD, Ponlapat Rojnuckarin, MD PhD, Cheng-Shyong Chang, MD, Kian Meng Chang, MD, Meng-Yao Lu, MD, Wen-Li Hwang, MD, Liang Piu Koh, MD, Tsai-Yun Chen, MD, Anskar YH Leung, MD, Lalita Norasetthada, MD, Shih-Chung Wang, MD, Ming-Chih Chang, MD, Kang-Hsi Wu, MD, Surapol Issaragrisil, MD
Journal: Blood
Blood (2015) 126 (23): 1217.
https://doi.org/10.1182/blood.V126.23.1217.1217
Published: 2015
Journal Articles

Different Adverse Event Profiles and Significant Hematological Improvement Are Noted When Deferasirox Was Used in Adult Patients with Chronic Transfusion-Related Iron Overload in Taiwan: Results from a Prospective Observational Clinical Trial

Free
Bor-Sheng Ko, Ming-Chih Chang, MD, Tzeon-Jye Chiou, MD, Te-Kau Chang, MD, Yeu-Chin Chen, MD, Sheng-Fung Lin, MD, Cheng-Shyong Chang, MD, Yin-Che Lu, MD, Su-Peng Yeh, MD, Tsai-Yun Chen, MD, Wei-Yu Chen, MD
Journal: Blood
Blood (2015) 126 (23): 4554.
https://doi.org/10.1182/blood.V126.23.4554.4554
Published: 2015
Journal Articles

Pegylated Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory and/or Elder Acute Myeloid Leukemia: The Preliminary Result of Phase II Trial

Free
Hui-Jen Tsai, MD PhD, Ming-Chung Wang, MD, Sheng-Fung Lin, MD, Ya-Ping Chen, MD PhD, Hui-Hwa Hsiao, MD PhD, Ching-Yuan Kuo, MD, Li-Tzong Chen, MD PhD, Tsai-Yun Chen, MD
Journal: Blood
Blood (2014) 124 (21): 984.
https://doi.org/10.1182/blood.V124.21.984.984
Published: 2014
Journal Articles

No Differences in Outcomes Between Patients Achieving Early Molecular Response at 3 Months and Those Achieving Optimal Response at 6 or 12 Months in Chronic Phase of Chronic Myeloid Leukemia Treated with Front-Line Imatinib: Taiwan CML Study

Free
Ming-Chung Kuo, MD, Tsai-Yun Chen, MD, Ming-Chung Wang, MD, Youngsen Yang, MD, Su-Peng Yeh, MD, Cheng-Shyong Chang, MD, Yii-Jenq Lan, MD, Chih-Cheng Chen, MD, Yu-Chieh Su, MD, Pei-Ching Hsiao, MD, Ching-Yuan Kuo, MD, Li-Yuan Bai, MD, Wen-Li Hwang, MD, Lee-Yung Shih, MD
Journal: Blood
Blood (2014) 124 (21): 4544.
https://doi.org/10.1182/blood.V124.21.4544.4544
Published: 2014